ストックスクリーナーアプリを入手
3.18
29.96%
-1.36
前日終値:
$4.54
開ける：
$3.6
24時間の取引高:
310.51K
Relative Volume:
5.33
時価総額：
$36.44M
収益：
$10.96M
当期純損益:
$-7.02M
株価収益率:
-4.9688
EPS:
-0.64
ネットキャッシュフロー:
$-3.72M
1週間 パフォーマンス:
+64.77%
1か月 パフォーマンス:
+43.57%
6か月 パフォーマンス:
-29.02%
1年 パフォーマンス:
-42.18%
1日の値動き範囲:
$3.00
$3.855
1週間の範囲:
$1.93
$4.98
52週間の値動き範囲:
$1.55
$5.61
Collplant Biotechnologies Ltd Stock (CLGN) Company Profile
CLGN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CLGN
Collplant Biotechnologies Ltd
|
3.18 | 22.11M | 10.96M | -7.02M | -3.72M | -0.64 |
|
ONC
Beone Medicines Ltd Adr
|
245.58 | 26.10B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
442.05 | 111.96B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.35 | 42.96M | 0 | 0 | 0 | 0.00 |
|
VRNA
Verona Pharma Plc Adr
|
81.20 | 6.39B | 0 | -153.72M | -103.81M | -2.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
490.28 | 63.52B | 14.09B | 4.50B | 2.96B | 39.28 |
Collplant Biotechnologies Ltd Stock (CLGN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2023-02-17 | 開始されました | Alliance Global Partners | Buy |
Collplant Biotechnologies Ltd (CLGN) 最新ニュース
Dow Edges Higher; Dell Shares Fall After Q1 Results - Benzinga
CollPlant Biotechnologies Launches Share Offering; Stock Drops - marketscreener.com
CollPlant Biotechnologies (CLGN) Rating and Price Target Analysis | CLGN Stock News - GuruFocus
CollPlant (CLGN) Announces $3.6M Direct Offering and Private Placement - GuruFocus
CollPlant Biotechnologies shares slide after announces capital raise of $3.6M through registered direct offering - MSN
CollPlant (CLGN) Announces New Share and Warrant Sale Agreement - GuruFocus
COLLPLANT BIOTECHNOLOGIES ANNOUNCES $3.6 MILLION REGISTERED DIRE - GuruFocus
CollPlant announces $3.6 million stock offering By Investing.com - Investing.com India
CollPlant announces $3.6 million stock offering - Investing.com Australia
CollPlant Raises $3.6M to Advance AbbVie Partnership and Breakthrough Regenerative Medicine Programs - Stock Titan
CollPlant Biotechnologies (NASDAQ:CLGN) Price Target Lowered to $12.00 at D. Boral Capital - Defense World
CollPlant Biotechnologies Reports Strong Q1 2025 Results - TipRanks
Collplant Biotechnologies Ltd reports results for the quarter ended March 31Earnings Summary - TradingView
CollPlant Biotechnologies Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com
CollPlant Biotechnologies (CLGN) Analyst Ratings Update | CLGN S - GuruFocus
CollPlant Biotechnologies (CLGN) Analyst Ratings Update | CLGN Stock News - GuruFocus
COLLPLANT BIOTECHNOLOGIES REPORTS 2025 FIRST QUARTER FINANCIAL R - GuruFocus
COLLPLANT BIOTECHNOLOGIES REPORTS 2025 FIRST QUARTER FINANCIAL RESULTS AND PROVIDES A CORPORATE UPDATE | CLGN Stock News - GuruFocus
COLLPLANT BIOTECHNOLOGIES REPORTS 2025 FIRST QUARTER FINANCIAL RESULTS AND PROVIDES A CORPORATE UPDATE - PR Newswire
CollPlant Biotechnologies (CLGN) Expected to Announce Quarterly Earnings on Wednesday - Defense World
Earnings Preview: CollPlant Biotechnologies - Nasdaq
Global Tissue Engineering Market Insights & Industry Outlook | - openPR.com
When Will CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Breakeven? - simplywall.st
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR FIRST QUARTER FINAN - GuruFocus
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR FIRST QUARTER FINANCIAL RESULTS - Financial Times
Renaissance Technologies LLC Acquires New Stake in CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) - Defense World
Here's Why We're A Bit Worried About CollPlant Biotechnologies' (NASDAQ:CLGN) Cash Burn Situation - Yahoo Finance
CLGNCollplant Biotechnologies Ltd Latest Stock News & Market Updates - Stock Titan
Collplant stock hits 52-week low at $2.14 amid market challenges - Investing.com India
Collplant stock hits 52-week low at $2.14 amid market challenges By Investing.com - Investing.com South Africa
CollPlant's Collink.3D® BioInks and Technologies Offer a Relevan - GuruFocus
FDA Animal Testing Phase-Out: How CollPlant's BioInk Tech Could Revolutionize Drug Safety Studies - Stock Titan
Collplant stock hits 52-week low at $2.47 amid market challenges By Investing.com - Investing.com South Africa
Collplant stock hits 52-week low at $2.47 amid market challenges - Investing.com India
CollPlant Biotechnologies’ (CLGN) Buy Rating Reaffirmed at D. Boral Capital - The AM Reporter
D. Boral Capital Reaffirms “Buy” Rating for CollPlant Biotechnologies (NASDAQ:CLGN) - Defense World
Collplant plans clinical trials for dermal filler and advances regenerative implants - MSN
CollPlant Biotechnologies (CLGN) to Release Earnings on Thursday - Defense World
CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Q4 2024 Earnings Call Transcript - Insider Monkey
CollPlant Biotechnologies Ltd (CLGN) Q4 2024 Earnings Call Highlights: Navigating Revenue ... - Yahoo
CollPlant Biotechnologies Ltd (CLGN) Q4 2024 Earnings Call Highl - GuruFocus
CollPlant Biotechnologies Ltd (CLGN) Q4 2024 Earnings Call Highlights: Navigating Revenue ... By GuruFocus - Investing.com Canada
CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Sees Large Decline in Short Interest - Defense World
COLLPLANT BIOTECHNOLOGIES REPORTS 2024 FINANCIAL RESULTS AND PROVIDES A CORPORATE UPDATE - StreetInsider.com
Earnings call transcript: Collplant Biotechnologies Q4 2024 misses forecasts - Investing.com India
CollPlant Biotechnologies Reports 2024 Financial Results - TipRanks
CollPlant’s Earnings Call: Mixed Outlook Amid Innovations - TipRanks
SEC Form 20-F filed by CollPlant Biotechnologies Ltd - Quantisnow
Collplant Biotechnologies Ltd reports results for the quarter ended December 31Earnings Summary - TradingView
Collplant stock hits 52-week low at $2.9 amid market challenges - Investing.com Australia
Collplant stock hits 52-week low at $2.9 amid market challenges By Investing.com - Investing.com South Africa
Collplant Biotechnologies Ltd (CLGN) 財務データ
収益
当期純利益
現金流量
EPS
1.89%
3.74%
大文字化:
|
ボリューム (24 時間):